Indian Cardiovascular Drugs Market Analysis


  • Type: Therapeutics Area
  • Published : April 2021
  • Region: Asia
  • Country: India
  • Report ID : 1202

  • Format: PPT, PDF

Indian Cardiovascular Drugs Market Size, Share & Industry Analysis, by Drug Type (Antihypertensive, Antihyperlipidemic, Anticoagulants, Antiplatelet Drugs, Others), by Disease Indication (Hypertension, Hyperlipidemia, Coronary Artery Disease, Arrhythmia, Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Forecast, 2019-2028.

SKU: 1202 Categories: ,

Report Overview

The Indian cardiovascular drugs market size stood at XX Billion in 2019 & is projected to reach USD XX Billion by 2028, exhibiting a CAGR OF 5.9%.

The market for CVDs in India is growing rapidly because of the complex lifestyle changes associated with urbanization and the epidemiologic and nutritional transitions that accompany economic development.

The cardiovascular diseases includes disorders of heart & blood vessels especially and includes the life-threatening conditions such as coronary heart disease, hypertension and hyperlipidaemia. Cardiovascular diseases results in conditions such as myocardial infraction i.e. heart attacks and strokes. The age-standardized prevalence of CVD in India per 100,000 people was around XX during the year 2019-2028.

It is noted that the prevalence of heart diseases and stroke in India has increased by XX% from 1990 to 2019. This shows the rising burden of the diseases on India. During the year 2016-19, CVD alone contributed to XX% of the total deaths in India among which, heart disease caused XX% whereas stroke contributed XX% of total deaths. The most prevalent conditions in India include ischemic heart disease, hypertensive heart disease, and cerebrovascular disease. One in 4 deaths in India are now because of CVDs with ischemic heart disease and stroke responsible for >80% of this burden.

Market Drivers

The Indian government spends just 1.2 % of the GDP on the health sector, which is among the lowest in the world. The market drivers for cardiovascular diseases are large population, growing economic prosperity, and the disease burden. The leading medical devices company spends approximately XX% in R&D as percentage ratio to sales. The growth of the cardiovascular devices market is primarily attributed to the increasing acquisitions and collaboration activities and increasing rate of obesity. On the other hand, growth opportunities in the developing nations and declining prices of coronary stents are likely to have a positive impact on the growth of the Asia Pacific cardiovascular devices market in the coming years. The technological advancements are leading to increasing adoption of the pacemakers, and one of the recent advancements include the development of a leadless pacemaker that is one-tenth the size of the predecessor devices by Medtronic.

1. Indian Cardiovascular Disease Market Overview………………………………….
A. Market Size
2. Market Growth Drivers………………………………………………………………….
A. Rise in India Prevalence of Disease
B. Growing R&D Investments and Reimbursement Policies
3. Major Cardiovascular Diseases……………………………………………………….
A. Ischemic Heart disease
B. Stroke
C. Heart Failure
D. Heart Valve Complications
4. Cardiovascular Disease Market Segmentation…………………………………..
A. Drug Class
I. Antihypertensive
I. Antihyperlipidemic
II. Anticoagulants
III. Antiplatelet
IV. Other
B. Disease Type
I. Arteriosclerosis
II. Cardiac Arrhythmias
III. Myocardial Infraction
IV. Acute Coronary Syndrome
V. Peripheral Artery Disease
VI. Coronary Artery Disease
C. Distribution Channel
I. Hospital
II. Pharmacies
III. Others
5. Cardiovascular Disease Major Drugs Market Share…………………………
A. Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape…………………………………………………………………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles…………………………………………………………………..
A. Abbott Laboratories Company overview, Product & Services, Strategies & Financials
B. Boston Scientific Company overview, Product & Services, Strategies & Financials
C. Medtronic Plc Terumo Corporation Company, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape………………………………
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth……………………………………………………
A. New Trends and Development of Cardiovascular Disease Market
B. Future Opportunities
10. Conclusion

Market Segmentation
By Drug Class:
Cardiovascular drugs market has been segmented based on cardiac disease type which comprises amlodipine, Lisinopril, Nifedine, Atenolol, Benazepril, Tranexamic acid, vasopressin, nylidrin, aprotinin, Nimodipine, Alprostadil and many others.

By Disease type:
Based on disease type the market has the various diseases like arteriosclerosis, cardiac arrhythmias, myocardial infraction, acute coronary syndrome, peripheral artery disease, coronary artery disease, hypertension, hyperlipidemia, thrombosis, cardiac failure disease and others.

By Distribution Channel:
On the basis of distribution channel, the market for cardiovascular drugs can be segmented into hospital pharmacies, retail pharmacies, online pharmacies, and others. The hospital segment is expected to dominate the market throughout the forecast period. VOC is the main reason for hospital admissions, leading to several visits of patients to hospitals every year. This is expected to favor the expansion of the hospital segment in the coming years. The increasing number of clinics is propelling the growth of the specialty clinics segment.

Major Players
Sales of medicines in India grew 9.8% year-on-year to ₹1.4trillion in the year 2018, with drugs used to treat chronic diseases leading sales growth. Anti-diabetic medicine sales has raised up by XX% year-on-year, with a new class of drugs called SGLT2 (sodium-glucose co-transporter, inhibitors driving growth, while cardiac care drugs has been raising by XX%. The major players for cardiovascular devices in India are Abbott Laboratories, Boston Scientific, Medtronic Plc, Terumo Corporation, W. L. Gore & Associates.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements